Overview

Update
IPO / Stock
Went Public on Aug 14, 2014 / NASDAQ:OTIC
Total Equity Funding
$153.44M in 5 Rounds from 12 Investors
Headquarters:
San Diego, CA
Description:
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Founders:
,
Categories:
Biopharma, Health Care, Biotechnology
Website:
http://www.otonomy.com
Social:

Company Details

Update

Otonomy was founded in 2008 by Avalon Ventures and experts in the otology field in order to build the premier company dedicated to the treatment of otic disorders via localized drug delivery. This approach has already been widely adopted for the delivery of short-acting antibiotics to treat otitis media through a tympanostomy tube. In addition, otolaryngologists have demonstrated that the injection of steroids into the middle ear cavity can provide a therapeutic effect for patients with acute inner ear disorders such as Ménière’s disease and sudden sensorineural hearing loss. Expansion of this effort holds great promise for the treatment of chronic hearing loss, severe vertigo, and even tinnitus.

The key to Otonomy's leading position in this nascent field is the development of a proprietary formulation platform that provides sustained drug exposure from a single administration. Broad application of this technology has already been established across a number of therapeutic classes and from these, three product candidates have been advanced into development.

Funding Rounds (5) - $153.44M

Update
DateAmount / RoundValuationLead InvestorInvestors
Apr, 2014$49M / Series D12
Sep, 2013$45.9M / Series C8
Sep, 2010$10.04M / Venture0
Aug, 2010$38.5M / Series B4
Jun, 2010$10M / Series A1

Current Team (7)

Update

Products (1)

Update

Offices/Locations (1)

Update
  • Headquarters

    6275 Nancy Ridge Drive,

    Suite 100

    San Diego, CA 92121

    USA

Images (1)

Update

Add Acquisitions

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos